94 related articles for article (PubMed ID: 9250812)
1. Retinoid resistance in leukemic cells.
Kizaki M; Ueno H; Matsushita H; Takayama N; Muto A; Awaya N; Ikeda Y
Leuk Lymphoma; 1997 May; 25(5-6):427-34. PubMed ID: 9250812
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.
Kizaki M; Matsushita H; Takayama N; Muto A; Ueno H; Awaya N; Kawai Y; Asou H; Kamada N; Ikeda Y
Blood; 1996 Sep; 88(5):1824-33. PubMed ID: 8781440
[TBL] [Abstract][Full Text] [Related]
3. 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia.
Miller WH; Jakubowski A; Tong WP; Miller VA; Rigas JR; Benedetti F; Gill GM; Truglia JA; Ulm E; Shirley M
Blood; 1995 Jun; 85(11):3021-7. PubMed ID: 7756637
[TBL] [Abstract][Full Text] [Related]
4. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.
Muindi J; Frankel SR; Miller WH; Jakubowski A; Scheinberg DA; Young CW; Dmitrovsky E; Warrell RP
Blood; 1992 Jan; 79(2):299-303. PubMed ID: 1309668
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein.
Kizaki M; Ueno H; Yamazoe Y; Shimada M; Takayama N; Muto A; Matsushita H; Nakajima H; Morikawa M; Koeffler HP; Ikeda Y
Blood; 1996 Jan; 87(2):725-33. PubMed ID: 8555497
[TBL] [Abstract][Full Text] [Related]
6. A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review).
Kizaki M; Fukuchi Y; Ikeda Y
Int J Mol Med; 1999 Oct; 4(4):359-64. PubMed ID: 10493975
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
8. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
9. Restoration of retinoid sensitivity by MDR1 ribozymes in retinoic acid-resistant myeloid leukemic cells.
Matsushita H; Kizaki M; Kobayashi H; Ueno H; Muto A; Takayama N; Awaya N; Kinjo K; Hattori Y; Ikeda Y
Blood; 1998 Apr; 91(7):2452-8. PubMed ID: 9516145
[TBL] [Abstract][Full Text] [Related]
10. Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells.
Kizaki M; Nakajima H; Mori S; Koike T; Morikawa M; Ohta M; Saito M; Koeffler HP; Ikeda Y
Blood; 1994 Jun; 83(11):3289-97. PubMed ID: 8193364
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
12. Retinoids and differentiation treatment: a strategy for treatment in cancer.
Cornic M; Agadir A; Degos L; Chomienne C
Anticancer Res; 1994; 14(6A):2339-46. PubMed ID: 7825969
[TBL] [Abstract][Full Text] [Related]
13. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
14. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994 Jun; 8(6):914-7. PubMed ID: 8207983
[TBL] [Abstract][Full Text] [Related]
15. [Biological parameters of the efficiency of retinoic acid in acute leukemia].
Chomienne C; Cornic M; Castaigne S; Lefebvre P; de Thé H; Dejean A; Degos L
C R Seances Soc Biol Fil; 1991; 185(6):456-63. PubMed ID: 1822394
[TBL] [Abstract][Full Text] [Related]
16. Retinoid target genes in acute promyelocytic leukemia.
Pitha-Rowe I; Petty WJ; Kitareewan S; Dmitrovsky E
Leukemia; 2003 Sep; 17(9):1723-30. PubMed ID: 12970771
[TBL] [Abstract][Full Text] [Related]
17. Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission.
Cornic M; Chomienne C
Leuk Lymphoma; 1995 Jul; 18(3-4):249-57. PubMed ID: 8535190
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition and proapoptotic activity induction by IIF and valproic acid on RA-resistant leukemia cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Tonelli R; Franzoni M; Pession A; Rocchi P; Ferreri AM
Anticancer Res; 2008; 28(1A):283-8. PubMed ID: 18383858
[TBL] [Abstract][Full Text] [Related]
19. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
[TBL] [Abstract][Full Text] [Related]
20. Targeting PKC delta-mediated topoisomerase II beta overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line.
McNamara S; Nichol JN; Wang H; Miller WH
Leukemia; 2010 Apr; 24(4):729-39. PubMed ID: 20200558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
